Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.
Clinical trial NCT04309981 · UNKNOWN
Trial details
- NCT number
- NCT04309981
- Sponsor
- Sara V. Latorre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2025-04-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.